Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1988 1
1989 1
1990 1
1992 1
1993 1
1994 1
1995 3
1996 2
1997 2
1998 3
1999 1
2000 1
2001 1
2002 2
2003 3
2005 1
2006 2
2007 2
2008 5
2009 6
2010 12
2011 14
2012 15
2013 17
2014 19
2015 21
2016 18
2017 23
2018 26
2019 18
2020 13
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20930090

206 results
Results by year
Filters applied: . Clear all
Page 1
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.
Meijer E, Bakker SJ, van der Jagt EJ, Navis G, de Jong PE, Struck J, Gansevoort RT. Meijer E, et al. Clin J Am Soc Nephrol. 2011 Feb;6(2):361-8. doi: 10.2215/CJN.04560510. Epub 2010 Oct 7. Clin J Am Soc Nephrol. 2011. PMID: 20930090 Free PMC article.
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT. Zittema D, et al. Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19. Clin J Am Soc Nephrol. 2012. PMID: 22516290 Free article.
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A, Lu Y, Kawano H, Horie S, Muto S. Nakajima A, et al. Clin Exp Nephrol. 2015 Dec;19(6):1199-205. doi: 10.1007/s10157-015-1101-7. Epub 2015 Feb 27. Clin Exp Nephrol. 2015. PMID: 25715868
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, de Jong PE, Gansevoort RT. Meijer E, et al. Am J Kidney Dis. 2010 Nov;56(5):883-95. doi: 10.1053/j.ajkd.2010.06.023. Am J Kidney Dis. 2010. PMID: 20888104
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT. Boertien WE, et al. Nephrol Dial Transplant. 2012 Nov;27(11):4131-7. doi: 10.1093/ndt/gfs070. Epub 2012 Apr 20. Nephrol Dial Transplant. 2012. PMID: 22523115
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Boertien WE, et al. Am J Kidney Dis. 2013 Mar;61(3):420-9. doi: 10.1053/j.ajkd.2012.08.038. Epub 2012 Oct 22. Am J Kidney Dis. 2013. PMID: 23089511 Free PMC article.
Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?
Casteleijn NF, Zittema D, Bakker SJ, Boertien WE, Gaillard CA, Meijer E, Spithoven EM, Struck J, Gansevoort RT. Casteleijn NF, et al. Am J Nephrol. 2015;41(3):248-56. doi: 10.1159/000382081. Epub 2015 Apr 25. Am J Nephrol. 2015. PMID: 25926129 Free article.
Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.
Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT. Zittema D, et al. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1553-62. doi: 10.2215/CJN.08690813. Epub 2014 Jul 3. Clin J Am Soc Nephrol. 2014. PMID: 24993447 Free PMC article.
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Boertien WE, et al. Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953
Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.
Harskamp LR, Gansevoort RT, Boertien WE, van Oeveren W, Engels GE, van Goor H, Meijer E. Harskamp LR, et al. Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1749-56. doi: 10.2215/CJN.09941014. Epub 2015 Jul 31. Clin J Am Soc Nephrol. 2015. PMID: 26231191 Free PMC article.
206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback